VIICTR Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (5)
Epigenomics: maternal high-fat diet exposure in utero disrupts peripheral circadian gene expression in nonhuman primates.
Factors affecting symptom presentation in an early-phase clinical trials clinic patient population.
Incidence of infusion reactions to anti-neoplastic agents in early phase clinical trials
INO80 Chromatin Remodeler Facilitates Release of RNA Polymerase II from Chromatin for Ubiquitin-Mediated Proteasomal Degradation
The NIH Roadmap Epigenomics Mapping Consortium.
See All 5 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Factors affecting symptom presentation in an early-phase clinical trials clinic patient population.
Factors affecting symptom presentation in an early-phase clinical trials clinic patient population. Invest New Drugs. 2020 08; 38(4):1166-1174.
View in:
PubMed
subject areas
Adolescent
Adult
Aged
Antineoplastic Agents
Clinical Trials, Phase I as Topic
Female
Humans
Male
Middle Aged
Neoplasms
Patient Reported Outcome Measures
Severity of Illness Index
Symptom Assessment
Young Adult